This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on march 8, 2019.Upon further investigation of the reported event, the following information is new and/or changed: d10 (device availability - added date returned to manufacturer).G4 (date received by manufacturer).G7 (indication that this is a follow-up report).H2 (follow-up due to additional information).The sample was received on march 19, 2019 and at that time, it was determined that the device reported was not a tcvs manufactured product.Therefore, there will not be any investigation information completed or submitted by tcvs.The investigation will be completed by the manufacturer.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|